These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2084496)

  • 1. Sensitivity of oral bacteria to imipenem and other antibiotics.
    Wilson M; Legg JA
    Microbios; 1990; 64(260-261):197-202. PubMed ID: 2084496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
    Piddock LJ; Johnson MM; Webber MA
    J Antimicrob Chemother; 2003 Sep; 52(3):500-2. PubMed ID: 12917244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic suseptibility of bacteria isolated from oral infections.
    Hunt DE; King TJ; Fuller GE
    J Oral Surg; 1978 Jul; 36(7):527-9. PubMed ID: 277637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment of oral anaerobic infections.
    Olson RE; Morello JA; Kieff ED
    J Oral Surg; 1975 Aug; 33(8):619-21. PubMed ID: 1056466
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and antibiotic susceptibility of microorganisms isolated from oral infectious disease.
    Turner JE; Mincer HH
    J Tenn Dent Assoc; 1974 Oct; 54(4):168-72, 215. PubMed ID: 4534223
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic efficacy in odontogenic infections.
    Gabrielson ML; Stroh E
    J Oral Surg; 1975 Aug; 33(8):607-10. PubMed ID: 1056464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological basis of oral infections and sensitivity to antibiotics.
    Prieto-Prieto J; Calvo A
    Med Oral Patol Oral Cir Bucal; 2004; 9 Suppl():15-8; 11-4. PubMed ID: 15580129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L; Sposini T; Bartoli A; Marconi P
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaerobic bacteria in orofacial abscesses.
    Botha SJ; Senekal R; Steyn PL; Coetzee WJ
    J Dent Assoc S Afr; 1993 Aug; 48(8):445-9. PubMed ID: 9508939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections.
    Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infections in the oral and maxillofacial areas: their prevalence (1983-1992) and the evolution of the antibiotic sensitivity of the microbes involved].
    Barna M; Gogălniceanu D; Apetrei C
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):203-10. PubMed ID: 9455368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
    Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
    J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility in oral bacteria.
    Dornbusch K
    Swed Dent J; 1980; 4(1-2):9-15. PubMed ID: 6930116
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activities of inorganic agents on six bacteria associated with oral infections by two susceptibility tests.
    Fang M; Chen JH; Xu XL; Yang PH; Hildebrand HF
    Int J Antimicrob Agents; 2006 Jun; 27(6):513-7. PubMed ID: 16713190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics.
    Kuriyama T; Williams DW; Yanagisawa M; Iwahara K; Shimizu C; Nakagawa K; Yamamoto E; Karasawa T
    Oral Microbiol Immunol; 2007 Aug; 22(4):285-8. PubMed ID: 17600542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U; Manncke B; Gerbracht K; Werner H
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro disk diffusion sensitivity of meropenem against bacterial pathogens in Harare.
    Obi CL; Makandiramba B; Tswana SA; Robertson V; Moyo SR; Nziramasanga P
    East Afr Med J; 1999 Jul; 76(7):365-9. PubMed ID: 10520362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.